BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity
Go back to BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity| (NYSE: CLVT) | Delayed: 1.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.89 | 52 Week High | $ | |||
| Open | $1.91 | 52 Week Low | $ | |||
| Day High | $1.94 | P/E | N/A | |||
| Day Low | $1.86 | EPS | $ | |||
| Volume | 3,637,122 | |||||
